title: Site-specific drug delivery to the middle-to-lower region of the small intestine reduces food-drug interactions that are responsible for low drug absorption in the fed state.
abstract: Food-drug interactions may reduce the bioavailability of drugs taken after meals (negative food effects). We designed enteric-coated tablets that start to disintegrate when they reach the middle-to-lower region of the small intestine, and examined whether they could reduce negative food effects in dogs. Tablets containing trientine as a model drug were coated with hypromellose acetate succinate (HPMCAS) with various values of succinoyl group content. The time lag of drug dissolution from these enteric-coated tablets in simulated intestinal fluid of pH 6.8 increased as the succinoyl group content was decreased. The AUC of trientine after oral administration of its aqueous solution to fed dogs was one-eighth of that in fasted dogs. The low drug absorption in fed dogs was improved when trientine was administered as enteric-coated tablets. The average ratio of AUC in the fed state to that in the fasted state increased with decreasing succinoyl group content of HPMCAS. Negative food effects completely disappeared after oral administration of tablets coated with HPMCAS having a succinoyl group content of 6.2% or less, which probably disintegrated in the middle-to-lower small intestine. Our results indicated that food-drug interactions were avoided by separating the main absorption site of drugs from that of food components.
authors.affiliation: Specialty Chemicals Research Center, Shin-Etsu Chemical Co., Ltd, 28-1, Nishifukushima, Kubiki-ku, Joetsu, Niigata 942-8601, Japan.
authors.forename: Fumié K
authors.initials: FK
authors.lastname: Tanno
authors.forename: Shinji
authors.initials: S
authors.lastname: Sakuma
authors.forename: Yoshie
authors.initials: Y
authors.lastname: Masaoka
authors.forename: Makoto
authors.initials: M
authors.lastname: Kataoka
authors.forename: Toshio
authors.initials: T
authors.lastname: Kozaki
authors.forename: Ryosei
authors.initials: R
authors.lastname: Kamaguchi
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Ikeda
authors.forename: Hiroyasu
authors.initials: H
authors.lastname: Kokubo
authors.forename: Shinji
authors.initials: S
authors.lastname: Yamashita
mesh_terms: D000818:Animals; D019540:Area Under Curve; D001682:Biological Availability; D004285:Dogs; D016503:Drug Delivery Systems; D018565:Food-Drug Interactions; D007421:Intestine, Small / Q000378:metabolism*; D008297:Male; D010599:Pharmacokinetics; D012995:Solubility; D013607:Tablets
chemical_list: D013607:Tablets